2025-04-08 18:36:43
Latest Post
Godrej Properties delivers its highest ever quarterly and full year bookings
Poonawalla Fincorp Launches Shopkeeper Loan Business
Revolt Motors Expands to 200 Dealerships, Targets 400 by FY26
Sobha Ltd - Real Estate Operational Update - Q4 FY 2024-25
Lemon Tree Hotels signs a new property in DarjeelingStock Report
Marksans Pharma Ltd Q3FY21 consolidated net profit up at Rs. 58.94 crore
Posted On : 2021-02-08 14:28:43( TIMEZONE : IST )
MARKSANS PHARMA LTD. has reported financial results for the period ended December 31, 2020.
Financial Results (Q3 FY20-21) - QoQ Comparison
The company has reported total income of Rs.355.19 crores during the period ended December 31, 2020 as compared to Rs.360.13 crores during the period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.58.94 crores for the period ended December 31, 2020 as against net profit / (loss) of Rs.50.73 crores for the period ended September 30, 2020.
The company has reported EPS of Rs.1.42 for the period ended December 31, 2020 as compared to Rs.1.21 for the period ended September 30, 2020.
| Financials | Q3 FY20-21 | Q2 FY20-21 | % Change |
| Total Income | ₹ 355.19 crs | ₹ 360.13 crs |  -1.37% |
| Net Profit | ₹ 58.94 crs | ₹ 50.73 crs |  16.18% |
| EPS | ₹ 1.42 | ₹ 1.21 | 17.36% |
Financial Results (Q3 FY20-21) - YoY Comparison
The company has reported total income of Rs.355.19 crores during the period ended December 31, 2020 as compared to Rs.287.67 crores during the period ended December 31, 2019.
The company has posted net profit / (loss) of Rs.58.94 crores for the period ended December 31, 2020 as against net profit / (loss) of Rs.29.56 crores for the period ended December 31, 2019.
The company has reported EPS of Rs.1.42 for the period ended December 31, 2020 as compared to Rs.0.71 for the period ended December 31, 2019.
| Financials | Q3 FY20-21 | Q3 FY19-20 | % Change |
| Total Income | ₹ 355.19 crs | ₹ 287.67 crs | 23.47% |
| Net Profit | ₹ 58.94 crs | ₹ 29.56 crs | 99.39% |
| EPS | ₹ 1.42 | ₹ 0.71 | 100% |
Financial Results (9 Months ended FY 20-21) - YoY Comparison
The company has reported total income of Rs.1046.66 crores during the 9 months period ended December 31, 2020 as compared to Rs.799.16 crores during the 9 months period ended December 31, 2019.
The company has posted net profit / (loss) of Rs.159.03 crores for the 9 months period ended December 31, 2020 as against net profit / (loss) of Rs.78.01 crores for the 9 months period ended December 31, 2019.
The company has reported EPS of Rs.3.83 for the 9 months period ended December 31, 2020 as compared to Rs.1.86 for the 9 months period ended December 31, 2019.
| Financials | 9 Months ended FY20-21 | 9 Months ended FY19-20 | % Change |
| Total Income | ₹ 1046.66 crs | ₹ 799.16 crs | 30.97% |
| Net Profit | ₹ 159.03 crs | ₹ 78.01 crs | 103.86% |
| EPS | ₹ 3.83 | ₹1.86 | 105.91% |
Shares of MARKSANS PHARMA LTD. was last trading in BSE at Rs.59.1 as compared to the previous close of Rs. 58.2. The total number of shares traded during the day was 85586 in over 499 trades.
The stock hit an intraday high of Rs. 59.35 and intraday low of 58.1. The net turnover during the day was Rs. 5013522.
